β2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels

Abstract

In this study we determined the prevalence and clinical associations of immune-complexescontaining beta-2-glycoprotein I (b₂GPI) in randomly selected SLE patients.

We studied 38 consecutive SLE patients attending the Rheumatology Unit. Previous arterial or venous-thrombosis were documented by the appropriate diagnostic test. Lipid profile including total cholesterol, LDL, VLDL, HDL and Lp(a) levels were determined from the sera of the fasting patients. Antibodies to cardiolipin, oxidized LDL and b₂GPI were detected employing ELISA. b2GPI containing IgG immune-complexes were assayed by using a dot-blot assay.

Fourteen SLE patients (36.8%) were found to be positive for the presence of IgG anti-b₂GPI antibodies. Ten of the SLE patients (26.3%) were found to have high levels of b₂GPI containing immune-complexes. There was a positive correlation between b₂GPI-IC levels and the occurrence of thrombocytopenia in the patients (P < 0.05). Furthermore, patients with SLE and venous thrombosis had higher levels of b₂GPI-IC when compared with thrombosis-free patients or with healthy controls (P < 0.05). Patients with higher Lp(a) levels (> 50 mg/dl) possessed higher levels of b₂GPI-IC as compared with patients with lower Lp(a) concentration (< 20 mg/dl) (P < 0.05).

These results suggest that IC-containing b₂GPI can help in defining a subpopulation of SLE patients with increased risk of thrombocytopenia and further aid in resolving mechanisms of immune-mediated tissue damage.

Keywords

APS β2GPI autoimunity Lp(a)immune-complex SLE

Get full access to this article

View all access options for this article.

References

Hughes GRV . The antiphospholipid syndrome: Ten years on . Lancet 1993; 342: 341–344 .

Roubey RSA . Immunology of the anti-phospholipid syndrome . Arthritis Rheum 1996; 39: 1444–1454 .

Tsutsumi A et al. Antibodies to b$2GPI and clinical manifestations in patients with systemic lupus erythematosus . Arthritis Rheum 1996; 39: 1466–1474 .

Simantov R et al. Activation of cultured endothelial cells by antiphopholipid antibodies . J Clin Invest 1995; 96: 2211–2219 .

George J et al. Differential effects of anti-b2GPI antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome . Circulation 1998; 97: 900–906 .

Chong BH , Brighton TC , Chesterman CN . Antiphospholipid anti-bodies and platelets . Semin Thromb Hemost 1995; 21: 76-76 .

Blank M et al. Immunization with anticardiolipin cofactor (beta-2 glycoprotein-I) induces antiphospholipid syndrome in naive mice . J Autoimmunity 1994; 7: 441–455 .

Garcia C et al. Induction of experimental antiphospholipid syndrome in PL/J mice following immunization with beta 2 glycoprotein I . Am J Reprod Immunol 1997; 37: 118–124 .

George J et al. Induction of early atherosclerosis in LDL receptor deficient mice immunized with beta 2 glycoprotein I . Circulation 1998; 15: 1108–1115 .

10.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematousus . Arthritis Rheum 1982; 25: 1271–1279 .

11.

Nezlin R . A dot blot assay for detection of antigens in immune complexes. In: Immunology Methods Manual. Vol. 1. Ed. I. Lefkovits . Academic Press, San Diego , 1998; 521–525.

12.

Tincani A et al. The anti-b2 glycoprotein I activity in human antiphospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native b2-glycoprotein I and preserved during species' evolution . J Immunol 1996; 157: 5732-5732 .

13.

Roubey RAS , Eisenberg RA , Harper MF , Winfield JB . ‘ Anticardiolipin antibodies' recognize b2-glycoprotein in the absence of phospholipids. Importance of antigen density and bivalent binding . J Immunol 1995; 154: 954–960 .

14.

Matsuura E et al. Anticardiolipin antibodies recognize b2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface . J Exp Med 1994; 179: 457-457 .

15.

George J et al. Target recognition of b2-glycoprotein I (b2GPI)-dependent anticardiolipin antibodies: Evidence for involvement of the IV domain of b2GPI in antibody binding . J Immunol 1998; 32: 116–125 .

16.

Blank M , Cohen J , Toder V , Shoenfeld Y . Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies . Proc Natl Acad Sci USA 1991; 88: 3069–3073 .

17.

Kandia DA , Krilis SA . Beta2-glycoprotein I . Lupus 1994; 3: 207–212 .

18.

Uttermann G . The mysteries of lipoprotein (a) . Science 1989; 246: 904–910 .

19.

Kochl S et al. Novel interaction of apolipoprotein (a) with b-2 glycoprotein I mediated by the kringle IV domain . Blood 1997; 90: 1482–1489 .